MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 250 filers reported holding MEDIVATION INC in Q2 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $5,850,000 | -29.0% | 51,227 | -19.7% | 0.15% | -28.0% |
Q1 2015 | $8,235,000 | -15.8% | 63,799 | -35.5% | 0.21% | -16.2% |
Q3 2014 | $9,776,000 | -25.2% | 98,878 | -41.7% | 0.25% | -21.8% |
Q2 2014 | $13,064,000 | -13.4% | 169,486 | -27.7% | 0.32% | -14.6% |
Q1 2014 | $15,094,000 | +19.5% | 234,491 | +18.5% | 0.37% | +12.5% |
Q4 2013 | $12,633,000 | -31.4% | 197,945 | -35.6% | 0.33% | -34.2% |
Q3 2013 | $18,413,000 | +14.5% | 307,193 | -6.0% | 0.50% | +8.2% |
Q2 2013 | $16,082,000 | +22.1% | 326,871 | +16.1% | 0.46% | +13.5% |
Q1 2013 | $13,169,000 | +20.1% | 281,630 | +31.4% | 0.41% | +14.3% |
Q4 2012 | $10,964,000 | – | 214,299 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |